Latest Options News

WhiteHawk Limited has raised A$1.5 million through a share placement to fund integration and growth of its newly acquired Quixxi Clarity AI platform, marking a strategic push into the AI governance market.

Wildcat Resources (ASX: WC8) has expanded its Bolt Cutter Central lithium discovery footprint beyond 2.3km with multiple high-grade spodumene intercepts, while advancing the Definitive Feasibility Study for its Tabba Tabba Project. The company maintains a strong cash position of A$43.3 million as it prepares for further drilling and development milestones.

Cuscal Limited has successfully raised A$30 million through a fully underwritten institutional placement to fund its acquisition of Paymark. The company also launched a Share Purchase Plan targeting an additional A$3 million from eligible shareholders.

Terrain Minerals’ latest drilling at its Lightning Gold Prospect reveals continuous high-grade gold mineralisation, expanding the system’s footprint and complexity. With a mining lease granted and a maiden JORC resource estimate due mid-year, the project is poised for a pivotal phase.

Nyrada has secured ethics approval to start its Phase IIa trial of Xolatryp in heart attack patients, with recruitment beginning in April 2026. The biotech also bolsters its cash position to AU$6.74 million and pursues new oncology indications.

OD6 Metals has revealed exceptional channel sampling results from its Horseshoe Prospect within the Quinn Fluorspar Project, confirming extensive ultra-high-grade fluorspar mineralisation with grades peaking at 82% CaF2. These findings underscore the project's potential for direct shipping ore and acid-grade fluorspar production.

GoldArc Resources is pushing aggressively towards near-term production at its Leonora Gold Project, leveraging over 24,000m of recent drilling and strategic partnerships that cover development costs. The company aims to start mining by late 2026, backed by a 200,000oz JORC resource and a seasoned technical team.

Hazer Group and KBR have completed a commercial-scale Process Design Package for a 30,000 tonnes per annum hydrogen plant, marking a key step toward industrial deployment of methane pyrolysis technology.

Forrestania Resources has revealed further high-grade niobium mineralisation from its maiden RC drilling at the Wozi Project, Malawi, validating a large near-surface system with grades up to 0.94% Nb2O5 and confirming the project's critical minerals potential.

BlackRock Investment Management has announced estimated cash distributions for its Australian iShares Balanced ESG and High Growth ESG ETFs, with key dates set for mid to late April 2026. Investors have until 15 April to opt into the Distribution Reinvestment Plan.

Telix Pharmaceuticals has initiated a US$550 million convertible bonds offering to refinance existing 2029 bonds and support general corporate purposes, securing low-cost, non-dilutive financing with a conversion premium above current share price.

Rhythm Biosciences has clarified inconsistencies in its disclosures around termination events in its underwriting agreement for RHYO options, following an ASX query. The company acknowledged an incomplete initial summary and administrative oversights but confirmed the agreement remains in full effect.